Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection

Helicobacter pylori is a spiral Gram-negative bacterium associated with inflammation of the gastric mucosa, peptic ulcer, and gastric adenocarcinoma, whose treatment has failed due to antibiotic resistance and side effects. Furthermore, because there are no vaccines effective against H. pylori, an a...

Full description

Saved in:
Bibliographic Details
Main Authors: David Espinosa-Ramos, Diana Caballero-Hernández, Ricardo Gomez-Flores, Armando Trejo-Chávez, Luis Jerónimo Pérez-Limón, Myriam Angélica de la Garza-Ramos, Reyes Tamez-Guerra, Patricia Tamez-Guerra, Cristina Rodriguez-Padilla
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2019/8595487
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558901703213056
author David Espinosa-Ramos
Diana Caballero-Hernández
Ricardo Gomez-Flores
Armando Trejo-Chávez
Luis Jerónimo Pérez-Limón
Myriam Angélica de la Garza-Ramos
Reyes Tamez-Guerra
Patricia Tamez-Guerra
Cristina Rodriguez-Padilla
author_facet David Espinosa-Ramos
Diana Caballero-Hernández
Ricardo Gomez-Flores
Armando Trejo-Chávez
Luis Jerónimo Pérez-Limón
Myriam Angélica de la Garza-Ramos
Reyes Tamez-Guerra
Patricia Tamez-Guerra
Cristina Rodriguez-Padilla
author_sort David Espinosa-Ramos
collection DOAJ
description Helicobacter pylori is a spiral Gram-negative bacterium associated with inflammation of the gastric mucosa, peptic ulcer, and gastric adenocarcinoma, whose treatment has failed due to antibiotic resistance and side effects. Furthermore, because there are no vaccines effective against H. pylori, an appropriate vaccine design targeting conserved/essential genes must be identified. In the present study, a H. pylori 50–52 kDa immunogen-derived peptide antigen with the sequence Met-Val-Thr-Leu-Ile-Asn-Asn-Glu (MVTLINNE) was used to immunize against H. pylori infection. For this, mice received an intraperitoneal injection of 100 μg of H. pylori peptide on the first week, followed by two weekly subcutaneous reinforcements and further 109 bacteria administration in the drinking water for 3 weeks. Thymic cells proliferative responses to concanavalin A, serum levels of IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, and TNF-α cytokines, and IgG1, IgG2a, IgG2b, IgG3 IgM, and IgA immunoglobulins were evaluated. Significant (p<0.05) increases on lymphoproliferation and spleen weights after immunization were observed. In contrast, infection significantly (p<0.05) decreased lymphoproliferation, which was recovered in immunized mice. In addition, levels of serum TH1 and TH2 cytokines were not altered after immunization, except for the significant increase in IL-6 production in immunized and/or infected animals. Moreover, immunization correlated with plasma secretory IgA and IgG, whereas infection alone only elicited IgM antibodies. Peptide immunization protected 100% of mice against virulent H. pylori. MVTLINNE peptide deserves further research as an approach to the prophylaxis of H. pylori infection.
format Article
id doaj-art-df4b16f0fb284c67b86f77b4a8a54ba7
institution Kabale University
issn 1712-9532
1918-1493
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-df4b16f0fb284c67b86f77b4a8a54ba72025-02-03T01:31:18ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95321918-14932019-01-01201910.1155/2019/85954878595487Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against InfectionDavid Espinosa-Ramos0Diana Caballero-Hernández1Ricardo Gomez-Flores2Armando Trejo-Chávez3Luis Jerónimo Pérez-Limón4Myriam Angélica de la Garza-Ramos5Reyes Tamez-Guerra6Patricia Tamez-Guerra7Cristina Rodriguez-Padilla8Universidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Medicina Veterinaria y Zootecnia, Departamento de Patobiología, Campus de Ciencias Agropecuarias, Escobedo, NL. C.P. 66050, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Odontología y Centro de Investigación y Desarrollo en Ciencias de la Salud, Unidad de Odontología Integral y Especialidades, Av. Dr. Aguirre Pequeño y Silao S/N, Monterrey, NL. C.P. 64460, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoUniversidad Autónoma de Nuevo León, Facultad de Ciencias Biológicas, Departamento de Microbiología e Inmunología, San Nicolás de los Garza, NL. C.P. 66450, MexicoHelicobacter pylori is a spiral Gram-negative bacterium associated with inflammation of the gastric mucosa, peptic ulcer, and gastric adenocarcinoma, whose treatment has failed due to antibiotic resistance and side effects. Furthermore, because there are no vaccines effective against H. pylori, an appropriate vaccine design targeting conserved/essential genes must be identified. In the present study, a H. pylori 50–52 kDa immunogen-derived peptide antigen with the sequence Met-Val-Thr-Leu-Ile-Asn-Asn-Glu (MVTLINNE) was used to immunize against H. pylori infection. For this, mice received an intraperitoneal injection of 100 μg of H. pylori peptide on the first week, followed by two weekly subcutaneous reinforcements and further 109 bacteria administration in the drinking water for 3 weeks. Thymic cells proliferative responses to concanavalin A, serum levels of IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, and TNF-α cytokines, and IgG1, IgG2a, IgG2b, IgG3 IgM, and IgA immunoglobulins were evaluated. Significant (p<0.05) increases on lymphoproliferation and spleen weights after immunization were observed. In contrast, infection significantly (p<0.05) decreased lymphoproliferation, which was recovered in immunized mice. In addition, levels of serum TH1 and TH2 cytokines were not altered after immunization, except for the significant increase in IL-6 production in immunized and/or infected animals. Moreover, immunization correlated with plasma secretory IgA and IgG, whereas infection alone only elicited IgM antibodies. Peptide immunization protected 100% of mice against virulent H. pylori. MVTLINNE peptide deserves further research as an approach to the prophylaxis of H. pylori infection.http://dx.doi.org/10.1155/2019/8595487
spellingShingle David Espinosa-Ramos
Diana Caballero-Hernández
Ricardo Gomez-Flores
Armando Trejo-Chávez
Luis Jerónimo Pérez-Limón
Myriam Angélica de la Garza-Ramos
Reyes Tamez-Guerra
Patricia Tamez-Guerra
Cristina Rodriguez-Padilla
Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
Canadian Journal of Infectious Diseases and Medical Microbiology
title Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
title_full Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
title_fullStr Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
title_full_unstemmed Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
title_short Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
title_sort immunization with a synthetic helicobacter pylori peptide induces secretory iga antibodies and protects mice against infection
url http://dx.doi.org/10.1155/2019/8595487
work_keys_str_mv AT davidespinosaramos immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT dianacaballerohernandez immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT ricardogomezflores immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT armandotrejochavez immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT luisjeronimoperezlimon immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT myriamangelicadelagarzaramos immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT reyestamezguerra immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT patriciatamezguerra immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection
AT cristinarodriguezpadilla immunizationwithasynthetichelicobacterpyloripeptideinducessecretoryigaantibodiesandprotectsmiceagainstinfection